Represents stock warrant conversion ratio as per the business combination agreement.

No definition available.

Name:	PTIX_BusinessCombinationStockWarrantConversionRatio
Namespace Prefix:	PTIX_
Data Type:	xbrli:pureItemType
Balance Type:	na
Period Type:	duration

- Definition

Expiration period of warrants or rights.

+ References

No definition available.

+ Details

Name:	PTIX_ClassOfWarrantOrRightExpirationPeriod
Namespace Prefix:	PTIX_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Aggregate intrinsic value of warrants outstanding.

+ References

No definition available.

+ Details

Name:	PTIX_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue
Namespace Prefix:	PTIX_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Weighted average price at which grantees can acquire the shares reserved for issuance under the warrant or right plan.

+ References

No definition available.

+ Details

Name:	PTIX_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
Namespace Prefix:	PTIX_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Modification of warrants.

+ References

No definition available.

+ Details

Name:	PTIX_ModificationOfWarrants
Namespace Prefix:	PTIX_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_AllocatedShareBasedCompensationExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Face (par) amount of debt instrument at time of issuance.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

+ Details

Name:	us-gaap_DebtInstrumentFaceAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Increase for accrued, but unpaid interest on the debt instrument for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_DebtInstrumentIncreaseAccruedInterest
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Unrecognized cost of unvested share-based compensation awards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of additional shares authorized for issuance under an established share-based compensation plan.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Gross number of share options (or share units) granted during the period.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Number of options outstanding, including both vested and non-vested options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.

+ References

No definition available.

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=PTIX_FormerConsultantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=PTIX_PredecessorWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=PTIX_PlacementAgentWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=PTIX_ProtagenicTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=PTIX_EmployeeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=PTIX_NonEmployeeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TitleOfIndividualAxis=PTIX_EmployeesConsultantsAndBoardMembersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=PTIX_StockOptionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_PlanNameAxis=PTIX_TheTwoThousandSixteenPlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Stockholders' Equity (Deficit) (Details Narrative)					12 Months Ended
Stockholders' Equity (Deficit) (Details Narrative)	Oct. 16, 2017 $ / shares shares	Oct. 16, 2017 $ / shares	Jan. 02, 2017 shares	Feb. 12, 2016 USD ($) $ / shares shares	Dec. 31, 2017 USD ($) $ / shares shares	Dec. 31, 2016 USD ($) $ / shares shares	Dec. 31, 2015 $ / shares shares
Share-based payment award, expiration period		48 months
Stock options outstanding					3,566,299	2,484,445	1,707,744
Stock options outstanding weighted average exercise price \| $ / shares					$ 1.33	$ 1.18	$ 0.84
Stock options intrinsic value \| $					$ 181,537
Number of stock options granted					1,103,000	1,308,300
Stock option weighted average exercise price per share \| $ / shares					$ 1.68	$ 1.25
Class of warrant or right, outstanding					3,826,658	3,826,658
Class of warrant or right, outstanding, weighted average exercise price \| $ / shares					$ 1.05	$ 1.05
Class of warrant or right outstanding, aggregate intrinsic value \| $					$ 763,342
Former Consultant [Member]
Class of warrant or right, number of securities called by warrants or rights					100,000
Class of warrant or right, expiration period					3 years
Modification of warrants \| $					$ 99,782
Series B Preferred Stock [Member] \| Predecessor Warrants [Member]
Class of warrant or right, number of securities called by warrants or rights				295,945
Class of warrant or right, exercise price of warrants or rights \| $ / shares				$ 1.25
Series B Preferred Stock [Member] \| Private Placement [Member]
Class of warrant or right, number of securities called by warrants or rights				423,291
Class of warrant or right, exercise price of warrants or rights \| $ / shares				$ 1.25
Class of warrant or right, expiration period				5 years
Series B Preferred Stock [Member] \| Private Placement [Member] \| Placement Agent Warrants [Member]
Class of warrant or right, number of securities called by warrants or rights				127,346
Class of warrant or right, exercise price of warrants or rights \| $ / shares				$ 1.25
Protagenic Therapeutics Inc [Member]
Business combination, stock warrant conversion ratio				1
Debt instrument, face amount \| $				$ 665,000
Debt instrument, increase, accrued interest \| $				$ 35,000
Protagenic Therapeutics Inc [Member] \| Predecessor Warrants [Member]
Class of warrant or right, number of securities called by warrants or rights				295,945
Class of warrant or right, exercise price of warrants or rights \| $ / shares				$ 1.25
Protagenic Therapeutics Inc [Member] \| Placement Agent Warrants [Member]
Class of warrant or right, number of securities called by warrants or rights				127,346
Class of warrant or right, exercise price of warrants or rights \| $ / shares				$ 1.25
Protagenic Therapeutics Inc [Member] \| Series B Preferred Stock [Member]
Number of stock options granted				1,807,744
Stock option weighted average exercise price per share \| $ / shares				$ 0.87
Class of warrant or right, number of securities called by warrants or rights				3,403,367
Class of warrant or right, exercise price of warrants or rights \| $ / shares				$ 1.03
Protagenic Therapeutics Inc [Member] \| Series B Preferred Stock [Member] \| Predecessor Warrants [Member]
Class of warrant or right, number of securities called by warrants or rights				295,945
Class of warrant or right, exercise price of warrants or rights \| $ / shares				$ 1.25
Protagenic Therapeutics Inc [Member] \| Series B Preferred Stock [Member] \| Private Placement [Member]
Class of warrant or right, number of securities called by warrants or rights				3,403,367
Class of warrant or right, exercise price of warrants or rights \| $ / shares				$ 1.05
Employee Stock Option [Member]
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized \| $					$ 1,796,263
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition					8 years 2 months 8 days
Employee [Member]
Compensation expense \| $					$ 635,400
Employee [Member] \| Employee Stock Option [Member]
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized \| $					1,039,638
Non-Employee [Member]
Compensation expense \| $					281,568
Non-Employee [Member] \| Employee Stock Option [Member]
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized \| $					$ 756,625
Employees Consultants and Board Members [Member]
Share-based payment award, expiration period	10 years
Number of stock options granted	953,000
Options strike price \| $ / shares	$ 1.75	$ 1.75
Employees Consultants and Board Members [Member] \| Minimum [Member]
Stock option granted vesting period	12 months
Employees Consultants and Board Members [Member] \| Maximum [Member]
Stock option granted vesting period	48 months
Stock Options [Member]
Number of stock options granted					1,103,000	1,308,300
Stock option weighted average exercise price per share \| $ / shares					$ 1.25	$ 1.75
Compensation expense \| $					$ 888,281	$ 546,134
The 2016 Plan [Member]
Number of additional shares grants for issuance			564,378
Number of shares available for grant			2,712,678
Share-based payment award, expiration period			10 years